News|Articles|September 2, 2004
- Pharmaceutical Technology-09-02-2004
- Volume 28
- Issue 9
Promoting Quality in Drug Manufacturing
Author(s)Jill Wechsler
FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards.
Advertisement
Articles in this issue
about 21 years ago
In the Spotlight-September 2004about 21 years ago
Automation in a Digital, Webbed, and Wireless Ageabout 21 years ago
September 2004about 21 years ago
Design of an Aseptic Process Simulationabout 21 years ago
Early Development Still Driving CRO Performanceabout 21 years ago
Particulate-Free PalletsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Frankfurt 2025: Regulatory Challenges for Global Manufacturing of Vaccines
2
AI and Accelerated Computing Propel the Biopharma Ecosystem Forward
3
Takeda Talks at CPHI Frankfurt 2025 About Smart Pharma Packaging Impacts
4
Thermo Fisher Launches OpenAI Partnership at CPHI Frankfurt 2025: Part One
5
